BamSEC and AlphaSense Join Forces
Learn More

Kinnate Biopharma Inc – Material Contracts

Formerly NASDAQ: KNTE

Material Contracts Filter

EX-10.14
from 10-K 4 pages Kinnate Biopharma, Inc. Amended and Restated Outside Director Compensation Policy
12/34/56
EX-10.2
from 8-K 10 pages Kinnate Biopharma Inc. Change in Control and Severance Agreement
12/34/56
EX-10.1
from 8-K 5 pages Via Email Neha Krishnamohan [Home Address and Email Address Redacted] Re: Employment Letter Dear Neha: On Behalf of Kinnate Biopharma Inc. (The “Company” or “We”), I Am Pleased to Offer You Employment on the Terms and Conditions Set Forth in This Employment Letter Agreement (The “Agreement”), Effective as of the Date on Which You Commence Employment With the Company (The “Effective Date”)
12/34/56
EX-10.16
from S-1/A 2 pages Amendment Number Three to Office Lease
12/34/56
EX-10.14
from S-1/A 4 pages Kinnate Biopharma, Inc. Outside Director Compensation Policy
12/34/56
EX-10.4
from S-1/A 24 pages Kinnate Biopharma Inc. 2020 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-1/A 46 pages Kinnate Biopharma Inc. 2020 Equity Incentive Plan
12/34/56
EX-10.15
from S-1 52 pages Office Lease Realty Income Properties 14, LLC, a Delaware Limited Liability Company, as Landlord, and Fount Therapeutics, LLC, a Delaware Limited Liability Company, as Tenant
12/34/56
EX-10.13
from S-1 10 pages Akinnate Biopharma Inc. Change in Control and Severance Agreement
12/34/56
EX-10.12
from S-1 10 pages Kinnate Biopharma Inc. Change in Control and Severance Agreement
12/34/56
EX-10.11
from S-1 10 pages Kinnate Biopharma Inc. Change in Control and Severance Agreement
12/34/56
EX-10.10
from S-1 10 pages Kinnate Biopharma Inc. Change in Control and Severance Agreement
12/34/56
EX-10.9
from S-1 7 pages Kinnate Biopharma Inc. Executive Incentive Compensation Plan
12/34/56
EX-10.8
from S-1 5 pages November 9, 2020 Richard Williams C/O Kinnate Biopharma Inc. 11975 El Camino Real Suite 101 San Diego, Ca 92130 Re: Confirmatory Employment Letter Dear Richard
12/34/56
EX-10.7
from S-1 5 pages November 9, 2020 Eric Murphy C/O Kinnate Biopharma Inc. 11975 El Camino Real Suite 101 San Diego, Ca 92130 Re: Confirmatory Employment Letter Dear Eric
12/34/56
EX-10.6
from S-1 5 pages November 9, 2020 Mark Meltz C/O Kinnate Biopharma Inc. 11975 El Camino Real Suite 101 San Diego, Ca 92130 Re: Confirmatory Employment Letter Dear Mark
12/34/56
EX-10.5
from S-1 5 pages November 9, 2020 Nima Farzan C/O Kinnate Biopharma Inc. 11975 El Camino Real Suite 101 San Diego, Ca 92130 Re: Confirmatory Employment Letter Dear Nima
12/34/56
EX-10.2
from S-1 50 pages Kinnate Biopharma Inc. 2018 Equity Incentive Plan
12/34/56
EX-10.1
from S-1 13 pages Kinnate Biopharma Inc. Indemnification Agreement
12/34/56
EX-10.12
from DRS/A 52 pages Office Lease Realty Income Properties 14, LLC, a Delaware Limited Liability Company, as Landlord, and Fount Therapeutics, LLC, a Delaware Limited Liability Company, as Tenant
12/34/56